Cargando…
Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV
BACKGROUND: HIV-associated neurocognitive disorders (HAND) have been suggested as persistent even with effective antiretroviral therapy (ART). Aims were to evaluate HAND prevalence and associated factors, in a large cohort of people-with-HIV (PWH). METHODS: ART-treated PWH, underwent a neuropsycholo...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907497/ https://www.ncbi.nlm.nih.gov/pubmed/35982541 http://dx.doi.org/10.1093/cid/ciac658 |
_version_ | 1784884183417487360 |
---|---|
author | Mastrorosa, Ilaria Pinnetti, Carmela Brita, Anna Clelia Mondi, Annalisa Lorenzini, Patrizia Del Duca, Giulia Vergori, Alessandra Mazzotta, Valentina Gagliardini, Roberta Camici, Marta De Zottis, Federico Fusto, Marisa Plazzi, Maria Maddalena Grilli, Elisabetta Bellagamba, Rita Cicalini, Stefania Antinori, Andrea |
author_facet | Mastrorosa, Ilaria Pinnetti, Carmela Brita, Anna Clelia Mondi, Annalisa Lorenzini, Patrizia Del Duca, Giulia Vergori, Alessandra Mazzotta, Valentina Gagliardini, Roberta Camici, Marta De Zottis, Federico Fusto, Marisa Plazzi, Maria Maddalena Grilli, Elisabetta Bellagamba, Rita Cicalini, Stefania Antinori, Andrea |
author_sort | Mastrorosa, Ilaria |
collection | PubMed |
description | BACKGROUND: HIV-associated neurocognitive disorders (HAND) have been suggested as persistent even with effective antiretroviral therapy (ART). Aims were to evaluate HAND prevalence and associated factors, in a large cohort of people-with-HIV (PWH). METHODS: ART-treated PWH, underwent a neuropsychological examination through a battery of 12 tests exploring 5 different domains, between 2009 and 2020, were included in this cross-sectional analysis. HAND were classified according to Frascati's criteria. Participants were defined as complaining or not-complaining if a cognitive complaint was reported or not. Chi-square for trend and multivariable logistic regression were fitted. RESULTS: Overall, 1424 PWH were enrolled during four three-years periods. HAND prevalence was 24%; among complainers (572/1424), it was 38%, higher than among not-complainers (15%). Over the study period, a decreasing HAND prevalence was found in the entire population (P < 0.001) and in complaining (P < 0.001); in not-complaining it remained stable (P = 0.182). Factors associated with HAND were older age, lower educational level, lower current CD4(+) T-cell count and HCV co-infection. Compared to nonnucleoside reverse transcriptase inhibitors, receiving dual and integrase strand transfer inhibitor (INSTI)-based therapies was associated with a decreased risk of HAND, as well as being tested in more recent years. CONCLUSIONS: In this large cohort of ART-treated PWH, mostly virologically suppressed, a remarkable decreasing HAND prevalence was observed. Besides HIV- and patient-related factors, the reduced risk of HAND found with dual and INSTI-based regimens along with a more recent ART initiation, could suggest a potential role of new treatment strategies in this decline, due to their greater virologic efficacy and better tolerability. |
format | Online Article Text |
id | pubmed-9907497 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-99074972023-02-09 Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV Mastrorosa, Ilaria Pinnetti, Carmela Brita, Anna Clelia Mondi, Annalisa Lorenzini, Patrizia Del Duca, Giulia Vergori, Alessandra Mazzotta, Valentina Gagliardini, Roberta Camici, Marta De Zottis, Federico Fusto, Marisa Plazzi, Maria Maddalena Grilli, Elisabetta Bellagamba, Rita Cicalini, Stefania Antinori, Andrea Clin Infect Dis Major Article BACKGROUND: HIV-associated neurocognitive disorders (HAND) have been suggested as persistent even with effective antiretroviral therapy (ART). Aims were to evaluate HAND prevalence and associated factors, in a large cohort of people-with-HIV (PWH). METHODS: ART-treated PWH, underwent a neuropsychological examination through a battery of 12 tests exploring 5 different domains, between 2009 and 2020, were included in this cross-sectional analysis. HAND were classified according to Frascati's criteria. Participants were defined as complaining or not-complaining if a cognitive complaint was reported or not. Chi-square for trend and multivariable logistic regression were fitted. RESULTS: Overall, 1424 PWH were enrolled during four three-years periods. HAND prevalence was 24%; among complainers (572/1424), it was 38%, higher than among not-complainers (15%). Over the study period, a decreasing HAND prevalence was found in the entire population (P < 0.001) and in complaining (P < 0.001); in not-complaining it remained stable (P = 0.182). Factors associated with HAND were older age, lower educational level, lower current CD4(+) T-cell count and HCV co-infection. Compared to nonnucleoside reverse transcriptase inhibitors, receiving dual and integrase strand transfer inhibitor (INSTI)-based therapies was associated with a decreased risk of HAND, as well as being tested in more recent years. CONCLUSIONS: In this large cohort of ART-treated PWH, mostly virologically suppressed, a remarkable decreasing HAND prevalence was observed. Besides HIV- and patient-related factors, the reduced risk of HAND found with dual and INSTI-based regimens along with a more recent ART initiation, could suggest a potential role of new treatment strategies in this decline, due to their greater virologic efficacy and better tolerability. Oxford University Press 2022-08-19 /pmc/articles/PMC9907497/ /pubmed/35982541 http://dx.doi.org/10.1093/cid/ciac658 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Major Article Mastrorosa, Ilaria Pinnetti, Carmela Brita, Anna Clelia Mondi, Annalisa Lorenzini, Patrizia Del Duca, Giulia Vergori, Alessandra Mazzotta, Valentina Gagliardini, Roberta Camici, Marta De Zottis, Federico Fusto, Marisa Plazzi, Maria Maddalena Grilli, Elisabetta Bellagamba, Rita Cicalini, Stefania Antinori, Andrea Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV |
title | Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV |
title_full | Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV |
title_fullStr | Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV |
title_full_unstemmed | Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV |
title_short | Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV |
title_sort | declining prevalence of human immunodeficiency virus (hiv)–associated neurocognitive disorders in recent years and associated factors in a large cohort of antiretroviral therapy–treated individuals with hiv |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907497/ https://www.ncbi.nlm.nih.gov/pubmed/35982541 http://dx.doi.org/10.1093/cid/ciac658 |
work_keys_str_mv | AT mastrorosailaria decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT pinnetticarmela decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT britaannaclelia decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT mondiannalisa decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT lorenzinipatrizia decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT delducagiulia decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT vergorialessandra decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT mazzottavalentina decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT gagliardiniroberta decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT camicimarta decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT dezottisfederico decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT fustomarisa decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT plazzimariamaddalena decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT grillielisabetta decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT bellagambarita decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT cicalinistefania decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv AT antinoriandrea decliningprevalenceofhumanimmunodeficiencyvirushivassociatedneurocognitivedisordersinrecentyearsandassociatedfactorsinalargecohortofantiretroviraltherapytreatedindividualswithhiv |